Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to Ophthalmology Times Europe.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
Cataract
MGD
Retina
 
 
Survey

What do you believe is the most appropriate glaucoma therapy option?

Monotherapy
26%
Multiple therapies
3%
Fixed-dose combinations
16%
Various/individualized treatment
55%

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.


November 26, 2014
Laser cataract surgery
Laser-assisted capsulotomy results better than CCC
Femtosecond laser-assisted capsulotomy resulted in better circularity and more predictable size compared with standard manual continuous curvilinear capsulorhexis (CCC) in a prospective, randomized clinical study by researchers in Italy. More...
Meibomian gland dysfunction
Thermodynamic treatment effective for MGD
A single thermodynamic treatment (LipiFlow, TearScience) can serve as an effective treatment of meibomian gland dysfunction (MGD), and the beneficial effects of the treatment can last for 6 months or longer, according to a recent study. More...
Limiting AMD progression
Laser shows promise in limiting AMD progression
A proprietary retinal laser technology has demonstrated the potential to reverse the accumulation of drusen in patients with high-risk early age-related macular degeneration (AMD) over a 24-month period. More...
Products in Practice Issue 3
Real world experience of leading ophthalmic products. Read more: